Azole agents (e.g., fluconazole or ketoconazole) and rifampin have not been used to treat hypercalcemia during pregnancy and postpartum in patients with pathogenic CYP24A1 mutations, but have been suggested as potential candidates for long-term treatment in this setting [9]. This evidence concerns the gene CYP24A1 and Hypercalcemia.